Aclarion, Inc. (ACON) NASDAQ
3.45
+0.33(+10.58%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.45
+0.33(+10.58%)
Currency In USD
Address
951 Mariners Island Boulevard
Broomfield, CA 94404
United States of America (the)
Phone
650-241-1741
Website
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
5
First IPO Date
April 22, 2022
| Name | Title | Pay | Year Born |
| Brent Ness | Chief Executive Officer, President & Director | 381,069 | 1967 |
| Ryan Bond | Chief Strategy Officer | 226,875 | 1972 |
| Gregory A. Gould | Chief Financial Officer | 285,913 | 1966 |
| Jeffrey John Thramann | Executive Chairman | 381,069 | 1965 |
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.